Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury
Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury
复制标题
DOI:
10.1046/j.1365-2036.2000.00739.x
复制
发表时间:
2000-05-01
影响因子:
7.6
通讯作者:
Hawkey, CJ
中科院分区:
文献类型:
--
作者:
Donnelly, MT;Goddard, AF;Hawkey, CJ
Introduction: The harmful effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the gastric mucosa and the prophylactic effects of misoprostol are both dose-dependent.Aim: To investigate whether a low-dose of misoprostol is sufficient to prevent gastric mucosal injury caused by low-dose aspirin.Methods: We conducted a double-blind placebo controlled parallel group endoscopic study in 32 evaluable volunteers. The main outcome measure was erosive injury (ulcers and superficial erosions) in the gastric mucosa over 28 days.Results: Most subjects developed erosions on aspirin 300 mg daily. This was significantly reduced by misoprostol 100 mu g daily. (Odds ratio 0.18, 95% CI: 0.07-0.48). There were no drug-related or gastrointestinal adverse events in subjects receiving misoprostol.Conclusion: Misoprostol 100 mu g daily can prevent low-dose aspirin induced gastric mucosal injury without causing identifiable adverse effects.